1. Home
  2. WTFC vs RGEN Comparison

WTFC vs RGEN Comparison

Compare WTFC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WTFC

Wintrust Financial Corporation

HOLD

Current Price

$141.22

Market Cap

9.5B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$166.26

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTFC
RGEN
Founded
1991
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WTFC
RGEN
Price
$141.22
$166.26
Analyst Decision
Strong Buy
Buy
Analyst Count
12
10
Target Price
$154.67
$174.90
AVG Volume (30 Days)
497.6K
617.0K
Earning Date
01-20-2026
02-19-2026
Dividend Yield
1.41%
N/A
EPS Growth
13.95
N/A
EPS
10.89
0.03
Revenue
$2,563,182,000.00
$707,890,000.00
Revenue This Year
$17.85
$17.84
Revenue Next Year
$5.85
$12.44
P/E Ratio
$13.00
$6,513.01
Revenue Growth
13.69
11.74
52 Week Low
$89.10
$102.97
52 Week High
$144.70
$182.52

Technical Indicators

Market Signals
Indicator
WTFC
RGEN
Relative Strength Index (RSI) 58.60 59.56
Support Level $142.44 $161.41
Resistance Level $143.97 $167.65
Average True Range (ATR) 2.26 4.54
MACD -0.26 0.20
Stochastic Oscillator 61.62 94.46

Price Performance

Historical Comparison
WTFC
RGEN

About WTFC Wintrust Financial Corporation

Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: